Abstract
Transport of therapeutic agents into the anterior segment of the eye is highly restricted by various anatomical and physiological barriers. Topical administration is the most convenient method of drug delivery for the treatment of anterior segment eye diseases. The global market for eye care products is approximately $12.5 billion and is growing at a rate of 9% every year. Eye drops account for 90% of all conventional ophthalmic formulations. However, it suffers from several disadvantages such as nasolacrimal drainage, loss in conjunctival blood circulation, tear dilution, normal tear drainage and reflux blinking. There is a need for alternate drug delivery systems which can address poor ocular absorption associated with conventional drug delivery systems. In this chapter, we have made an attempt to briefly describe various drug delivery systems employed in the treatment of anterior segment eye diseases such as nanoemulsions, collagen corneal shields, hydrogels, vesicular systems (liposomes and niosomes), iontophoresis, phonophoresis, punctal plugs and contact lenses.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
